ScholarLens Back to search
1983•Current Medical Research and OpinionRequires access

Sulindac versus piroxicam in the treatment of osteoarthritis

P. G. Janke, Paul Williams, Peter Williams, Jane B. Diggins

Open publisher page 6 citations

Abstract

Twenty-nine patients with osteoarthritis of the hip and/or knee(s) were entered into an 8-week, open, parallel group study of sulindac (400 mg daily) and piroxicam (20 mg daily). The results showed that both drugs produced improvements in the patients' overall condition with a trend for sulindac to be superior to piroxicam. There was no difference between the two drugs in terms of adverse reactions. Overall, both drugs proved beneficial and had an acceptable side-effect profile.

About this research paper

What this paper is about

Twenty-nine patients with osteoarthritis of the hip and/or knee(s) were entered into an 8-week, open, parallel group study of sulindac (400 mg daily) and piroxicam (20 mg daily). The results showed that both drugs produced improvements in the patients' overall condition with a trend for sulindac to be superior to piroxicam. There was no difference between the two drugs in terms of adverse reactions. Overall, both drugs proved beneficial and had an acceptable side-effect profile.

Why it matters

OpenAlex reports 6 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Twenty-nine patients with osteoarthritis of the hip and/or knee(s) were entered into an 8-week, open, parallel group study of sulindac (400 mg daily) and piroxicam (20 mg daily). The results showed that both drugs produced improvements in the patients' overall condition with a trend for sulindac to be superior to piroxicam. There was no difference between the two drugs in terms of adverse reactions. Overall, both drugs proved beneficial and had an acceptable side-effect profile.

Key concepts: Piroxicam, Medicine, Sulindac, Osteoarthritis, Adverse effect, Internal medicine, Anesthesia, Pharmacology

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Sulindac versus piroxicam in the treatment of osteoarthritis — Research Paper | ScholarLens